original ) (raw )Predictive Factors for Urinary Toxicity from a Multi-Center Trial of Stereotactic Body Radiation Therapy for Prostate Cancer
Najeeb Mohideen
International Journal of Radiation Oncology*Biology*Physics, 2018
View PDFchevron_right
Dose to the bladder neck is the most important predictor for acute and late toxicity after low-dose-rate prostate brachytherapy: implications for establishing new dose constraints for treatment planning
Gil'ad N Cohen
International journal of radiation oncology, biology, physics, 2014
View PDFchevron_right
Clinical characteristics and management of late urinary symptom flare following stereotactic body radiation therapy for prostate cancer
Aditi Bhagat , Leonard Chen
Frontiers in oncology, 2014
View PDFchevron_right
Late urinary toxicity modeling after stereotactic body radiotherapy (SBRT) in the definitive treatment of localized prostate cancer
Leonard Chen
Acta Oncologica, 2015
View PDFchevron_right
Dose-volume analysis and the temporal nature of toxicity with stereotactic body radiation therapy for prostate cancer
Mack Roach
Practical Radiation Oncology, 2015
View PDFchevron_right
Urinary toxicity after high dose intensity modulated radiotherapy as primary therapy for prostate cancer
Valérie Fonteyne
Radiotherapy and Oncology, 2009
View PDFchevron_right
Association of urethral toxicity with dose exposure in combined high-dose-rate brachytherapy and intensity-modulated radiation therapy in intermediate- and high-risk prostate cancer
Daniel M Aebersold
Radiotherapy and Oncology, 2009
View PDFchevron_right
Relationships between bladder dose–volume/surface histograms and acute urinary toxicity after radiotherapy for prostate cancer
Francesco Civardi
Radiotherapy and Oncology, 2014
View PDFchevron_right
Acute Urinary Morbidity Following Stereotactic Body Radiation Therapy for Prostate Cancer with Prophylactic Alpha-Adrenergic Antagonist and Urethral Dose Reduction
Robyn Cyr
Frontiers in Oncology, 2016
View PDFchevron_right
Time Course and Accumulated Risk of Severe Urinary Adverse Events After High- Versus Low-Dose-Rate Prostate Brachytherapy With or Without External Beam Radiation Therapy
Dennis Shrieve
International Journal of Radiation Oncology*Biology*Physics, 2016
View PDFchevron_right
Stereotactic Body Radiation Therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience
viola chen
Radiation Oncology, 2013
View PDFchevron_right
Post Intensity-Modulated Radiation Therapy Urinary Function for Prostate Cancer; A Prospective Study
Amirhossein Rahavian
2020
View PDFchevron_right
Toxicity Profile With a Large Prostate Volume After External Beam Radiotherapy for Localized Prostate Cancer
Michael Pinkawa
International Journal of Radiation Oncology*Biology*Physics, 2008
View PDFchevron_right
Patient-reported urinary incontinence following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer
Leonard Chen
Radiation oncology (London, England), 2014
View PDFchevron_right
Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer
Leonard Chen
Radiation Oncology, 2014
View PDFchevron_right
Urinary bladder dose–response relationships for patient-reported genitourinary morbidity domains following prostate cancer radiotherapy
Morten Høyer
Radiotherapy and Oncology, 2016
View PDFchevron_right
Dosimetric correlations with urinary quality of life in patients receiving post-prostatectomy radiation therapy
Panayiotis Mavroidis
Journal of Radiation Oncology, 2020
View PDFchevron_right
Dosimetric predictors of toxicity and quality of life following prostate stereotactic ablative radiotherapy
Alexandre Mamedov
Radiotherapy and Oncology, 2020
View PDFchevron_right
Acute side effects after definitive stereotactic body radiation therapy (SBRT) for patients with clinically localized or locally advanced prostate cancer: a single institution prospective study
Csaba Polgar
Radiology and Oncology, 2021
View PDFchevron_right
Long-term Toxicity and Health-related Quality of Life after Single-fraction High Dose Rate Brachytherapy Boost and Hypofractionated External Beam Radiotherapy for Intermediate-risk Prostate Cancer
Geraldine Goss
Clinical Oncology, 2017
View PDFchevron_right
Dosimetric analysis of radiation therapy oncology group 0321: The importance of urethral dose
I-chow Hsu
Practical Radiation Oncology, 2014
View PDFchevron_right
Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer
Harcharan Gill
2012
View PDFchevron_right
Five-year prospective patient evaluation of bladder and bowel symptoms after dose-escalated radiotherapy for prostate cancer with the BeamCath® technique
Per Fransson
International Journal of Radiation Oncology*Biology*Physics, 2006
View PDFchevron_right
Late Urinary Morbidity With High Dose Prostate Brachytherapy as a Boost to Conventional External Beam Radiation Therapy for Local and Locally Advanced Prostate Cancer
Eduardo Ribeiro
Journal of Urology, 2004
View PDFchevron_right